$208.10
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Country

US

CEO

Mr. James Davis

IPO date

1996

Employees

46,000

ISIN

US74834L1008

Key stats

Open

$208.10

Volume

621.52K

Market cap

$23.05B

Prev. close

$208.05

Impl / hst vl

-

Open interest

$0.00

$208.10

Day’s Range

$208.10

$171.18

52W Range

$219.20

Valuation

38
Valuation score
Overvalued
P/E
22.65
P/S
2.06
P/B
3.15
Current ratio
1.18
Debt / Equity
0.71
ROE
14.11%
Gross margin
32.61%
Income growth
2.45%
FCF growth
-46.58

Jul

22

Dividends

The last payment date was Jul 22, 2026

Div. per Share

$0.86

Div. Yield

0.41%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 10 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$226.33
The top 19 analysts forecasts that 12-month price may increase by 8.76%, with a low of $181.02 and a high of $257.25
$181.02
Low
$226.33
Avg
$257.25
High
Current price

Earnings

Q1 ‘26 revenue
$2.90B
Q1 ‘26 net income
$251.00M
Revenue
Net income
Previous EPS
$2.50
Estimate EPS
$2.86
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply